查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997206

膜式氧气供应市场：2026-2032年全球市场预测（依产品类型、材料、流动配置、温度、应用和最终用户划分）

Membrane Oxygenators Market by Product Type, Material, Flow Configuration, Temperature, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，膜氧供应市场价值将达到 7.0416 亿美元，到 2026 年将成长至 7.5617 亿美元，到 2032 年将达到 11.1433 亿美元，年复合成长率为 6.77%。

主要市场统计数据
基准年 2025 7.0416亿美元
预计年份：2026年 7.5617亿美元
预测年份：2032年 11.1433亿美元
复合年增长率 (%) 6.77%

对膜式氧气输送系统进行全面概述：涵盖临床要求、技术基础、监管压力以及相关人员。

膜式氧合系统是体外生命维持和外科灌注的一项基础技术，它作为血气交换介面，在心肺体外迴圈手术和长时间体外膜氧合（ECMO）期间维持氧合併清除二氧化碳。其设计、材料以及与监测系统的整合不仅决定了临床性能，还决定了其可抛弃性、生物相容性和在高压环境下的易用性。随着临床实务朝向更复杂的急诊医学和门诊手术发展，氧合装置的可靠性和可预测性对患者预后仍然至关重要。

材料创新、设备小型化、数位化整合和分散式临床实践如何重新定义膜式氧气输送设备的设计、製造和采购标准？

在临床需求、材料科学和系统整合的推动下，膜式氧合技术经历了变革性的变化。中空纤维结构结合高品质聚甲基戊烯膜和改进的表面涂层，已基本取代了高性能体外循环支持系统中传统的板式结构，从而提高了气体交换效率和血液相容性。同时，製造精度和灭菌製程的进步使得一次性氧合器能够大规模生产，满足严格的无菌性和可追溯性要求，并简化了手术室的后勤保障。

分析 2025 年美国预期关税调整对膜氧供应产业相关人员的供应链、采购和创新所产生的累积影响。

预计2025年的贸易政策变化和关税调整将对膜式氧合器的供应链、筹资策略和价格趋势产生重大影响。氧合器高精度製造所需的许多零件和材料都来自跨境供应链，进口原材料、聚合物树脂或成品的关税增加可能会推高製造商和下游买家的收货成本。这项变更可能会促使供应商和原始设备製造商（OEM）重新审视筹资策略，加快对国内或近岸合作伙伴的供应商认证，并考虑建立本地库存缓衝，以在贸易环境波动的情况下维持供应的连续性。

细分主导的洞察揭示了设备架构、临床应用、最终用户优先级、材料科学、流动配置和热通讯协定如何相互交织，从而塑造产品策略。

深入的市场细分阐明了产品功能、临床应用案例和组织采购优先事项如何相互交织，从而塑造需求和创新路径。按类型划分，市场研究主要集中在平板和中空纤维结构。平板设计在特定的桌上型研究和特殊低流量场景中具有独特的应用价值，而中空纤维结构则在体外临床应用中占据主导地位，因为在这些应用中，表面积体积比和紧凑的外形规格至关重要。从应用角度来看，市场研究主要围绕着「研究性血液氧合」、「心肺体外迴圈」和「体外膜氧合（ECMO）」。 “研究性血液氧合”进一步细分为“动物实验”和“体外测试”，这两者主要驱动材料测试和临床前性能检验。 「心肺体外迴圈」则进一步细分为冠状动脉绕道手术和瓣膜置换术，这两种手术都涉及不同的灌注时间曲线和抗凝血管理挑战。此外，体外膜氧合（ECMO）可进一步分为静脉-动脉ECMO和静脉-静脉ECMO。这反映了不同的血流动力学和氧合需求，这些需求会影响膜的选择和血流结构。

美洲、欧洲、中东、非洲和亚太市场在临床应用、监管多样性和製造能力方面的区域差异，塑造了膜氧供应业务的不同策略。

区域差异影响着临床实践、监管流程和采购框架，对製造商和医疗保健系统都具有重大意义。在美洲，领先的体外循环治疗机构集中于此，法规环境强调上市后监管和医疗设备可追溯性，供应链兼顾国内生产和策略性进口，这些因素共同塑造了临床应用。这些趋势为那些拥有可靠的临床数据、可扩展的生产能力和响应迅速的服务模式的公司创造了商机。

膜氧供应供应商之间的竞争与合作趋势，重点在于材料创新、智慧财产权定位、生产规模扩大和服务差异化。

膜氧合供应市场的竞争格局呈现出专业製造商、大型医疗设备原始设备製造商 (OEM) 和灵活高效的契约製造的局面。市场领导者和创新新参与企业都在投资于可减少血栓形成的涂层技术、可延长设备使用寿命的膜材料以及可提高批次间一致性的生产过程。医疗设备设计商与临床研究中心之间的策略合作正在加速实证医学证据的产生，而与契约製造製造商和包装专家的合作则有助于更快地扩大生产规模和拓展地域覆盖范围。

为了推动永续采用，高阶主管需要采取切实可行的、优先的措施来加强供应链、加速材料创新、模组化平台和深化临床伙伴关係。

产业领导者需要实施多方面的措施，以赢得临床机构的信任、保障利润率并确保供应的连续性。首先，应尽可能优先考虑供应商多元化和近岸外包，以降低进口关税和物流波动风险。关键原材料的双重采购以及选择替代聚合物供应商将显着提高韧性。其次，应加快对聚甲基戊烯加工能力和检验的表面处理技术的投资，这些技术能够有效降低血液相容性风险，因为这些特性正日益成为灌注师和重症监护团队采购决策中的重要因素。第三，应在产品系列设计中融入模组化理念，使同一核心氧合器平台能够透过定製配置器和附件套件，满足冠状动脉绕道手术术、瓣膜置换术（VA-ECMO）和静脉-静脉体外膜肺氧合（VV-ECMO）等不同应用场景的需求。

技术和商业性见解透过严格的多模态调查方法检验，该方法结合了专家访谈、临床文献综述、监管分析和供应商分析。

本研究采用多层次调查方法，旨在确保研究结果的可重复性、临床相关性和商业性适用性。主要研究内容包括对临床医生、灌注师、采购负责人和生产负责人进行结构化访谈，以了解实际应用中的表现预期、采购限制和营运考虑。次要研究整合了同行评审的临床文献、监管文件、医疗设备标籤检视、专利系列和标准指南，以检验技术声明并建立基准性能标准。供应商资讯分析和生产能力评估结合了公开资讯、行业名录和现场数据，以确定产能限制和区域生产地点。

整合临床、技术、监管和供应链优先事项的策略结论，指导膜氧合领域稳健、以临床为中心的决策。

总之，膜氧合系统处于临床表现、材料工程和供应链策略的关键交汇点。设计选择，特别是膜结构、聚合物选择和表面化学方面的选择，直接影响心肺体外迴圈、体外膜氧合（ECMO）和研究应用中的临床结果。监管预期、临床环境分散化和新的贸易政策的相互作用，要求相关人员采取稳健的筹资策略、有针对性的临床证据生成和产品模组化，以保持竞争力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 膜法制氧市场：依产品类型划分

  • 心肺体外迴圈用氧合器
    • 成人心肺氧化剂
    • 儿童心肺氧化剂
    • 新生儿心肺氧化剂
  • 体外生命维持氧合器
    • 静脉-动脉体外膜氧合器
    • 静脉-动脉体外膜氧合器
    • 混合/可配置型体外膜氧合器
  • 整合式氧合器和热交换器
  • 独立式氧合器（无热交换器）

第九章 膜法制氧市场：依材料分类

  • 聚甲基戊烯
  • 聚丙烯
  • 聚砜

第十章 膜式氧气供应市场：依流量配置划分

  • 封闭式
  • 打开

第十一章 以温度分類的膜法製氧市场

  • 低温
  • 室温

第十二章 膜法制氧市场：依应用领域划分

  • 用于研究目的的血氧饱和度
    • 动物实验
    • 体外试验
  • 心肺体外迴圈
    • 冠状动脉绕道手术手术
    • 瓣膜置换术
  • 体外膜氧合器（ECMO）
    • 静脉-动脉体外膜氧合（VaECMO）
    • 静脉体外膜氧合（ECMO）

第十三章 膜法制氧供应市场：依最终用户划分

  • 门诊手术中心
  • 医院和研究机构

第十四章 膜法制氧供应市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 膜法制氧供应市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 膜法制氧供应市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国膜法制氧供应市场

第十八章：中国膜法制氧供应市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Asahi Kasei Medical Co., Ltd.
  • BRAILE BIOMEDICA INDUSTRIA COMERCIO E REPRESENTACOES LTDA
  • Chalice Medical Ltd
  • CytoSorbents Corporation
  • Dongguan Kewei Medical Instrument Co., Ltd.
  • EUROSETS Srl
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • LivaNova PLC
  • Medtronic PLC
  • Merck KGaA
  • MicroPort Scientific Corporation
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Shandong Weigao Group Medical Polymer Company Limited
  • Terumo Corporation
  • Xenios AG
Product Code: MRR-3E7F10ED1B0D

The Membrane Oxygenators Market was valued at USD 704.16 million in 2025 and is projected to grow to USD 756.17 million in 2026, with a CAGR of 6.77%, reaching USD 1,114.33 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 704.16 million
Estimated Year [2026] USD 756.17 million
Forecast Year [2032] USD 1,114.33 million
CAGR (%) 6.77%

A comprehensive orientation to membrane oxygenators that frames clinical imperatives, technological underpinnings, regulatory pressures, and strategic priorities for industry stakeholders

Membrane oxygenators are a foundational technology in extracorporeal life support and surgical perfusion, serving as the blood-gas exchange interface that sustains oxygenation and carbon dioxide removal during cardiopulmonary bypass procedures and prolonged extracorporeal membrane oxygenation. Their design, materials, and integration with monitoring systems determine not only clinical performance but also disposability, biocompatibility, and ease of use in high-acuity settings. As clinical practice evolves toward more complex critical care applications and ambulatory surgical interventions, oxygenator reliability and predictability remain pivotal to patient outcomes.

Increasingly, clinicians demand devices that balance physiologic performance with operational efficiency. This has driven parallel developments in membrane geometry, fiber fabrication, and surface chemistry to reduce hemolysis, complement activation, and thrombogenicity while maintaining low transmembrane pressure gradients. At the same time, regulatory expectations for single-use devices, sterilization validation, and human factors engineering have sharpened product development priorities. Taken together, these technical and clinical drivers frame the remainder of this executive summary and set the stage for strategic decisions across manufacturing, procurement, and clinical adoption.

How material innovations, device miniaturization, digital integration, and decentralized clinical practice are redefining design, manufacturing, and procurement standards in membrane oxygenation

The membrane oxygenator landscape has undergone transformative shifts driven by clinical need, materials science, and systems integration. Hollow fiber architectures, coupled with advanced polymethylpentene membranes and refined surface coatings, have largely supplanted earlier flat sheet approaches for high-performance extracorporeal support, yielding improvements in gas transfer efficiency and hemocompatibility. Parallel advances in manufacturing fidelity and sterilization processes have enabled scaled production of single-use oxygenators that meet stringent sterility and traceability expectations, while also simplifying operating room logistics.

Concurrently, the clinical environment for these devices is decentralizing. Increased use of extracorporeal membrane oxygenation in nontraditional settings, expansion of ambulatory surgical centers performing complex procedures, and greater reliance on simulation and point-of-care diagnostics have shifted demand toward more modular, user-friendly devices with integrated monitoring. Digital health integration-including real-time sensor telemetry and decision-support algorithms-has enhanced clinician ability to titrate therapy and preempt complications. Sustainability has emerged as a secondary yet growing priority, prompting manufacturers to evaluate lifecycle impacts and to explore recyclable packaging, reduced material footprints, and production waste reduction. Together, these shifts are reshaping development roadmaps, go-to-market strategies, and the criteria by which purchasers evaluate product value.

Analyzing the cumulative supply chain, procurement, and innovation consequences of United States tariff adjustments anticipated in 2025 for membrane oxygenator stakeholders

Anticipated trade policy changes and tariff adjustments in the United States during 2025 carry important implications for membrane oxygenator supply chains, procurement strategies, and price dynamics. Many oxygenator components and high-precision manufacturing inputs originate in cross-border supply chains, and increased duties on imported raw materials, polymer resins, or finished components may elevate landed costs for manufacturers and downstream purchasers. This shift tends to incentivize both suppliers and OEMs to reassess sourcing strategies, accelerate supplier qualification for domestic or nearshore partners, and consider localized inventory buffers to maintain continuity of supply under fluctuating trade conditions.

The cumulative effect of tariff-driven cost pressures often manifests through slower new product introductions and more conservative inventory management in the near term, as manufacturers prioritize margin protection and supply stability. In response, several mitigation pathways are practicable: diversifying the supplier base to reduce single-source exposure; qualifying alternate materials that preserve clinical performance while improving tariff treatment; and implementing contract manufacturing agreements in tariff-favored jurisdictions. For purchasers, longer procurement lead times and revised total-cost-of-ownership calculations will require renewed emphasis on supplier transparency and collaborative forecasting. Ultimately, trade policy is accelerating strategic decisions around vertical integration, supplier partnerships, and design choices that can reduce vulnerability to import duties while sustaining clinical performance standards.

Segmentation-driven insights that reveal how device architecture, clinical application, end-user priorities, material science, flow configuration, and thermal protocols intersect to inform product strategy

Insightful segmentation clarifies how product features, clinical use cases, and organizational purchasing priorities intersect to shape demand and innovation pathways. Based on Type, the market is studied across Flat Sheet and Hollow Fiber architectures; flat sheet designs retain niche applicability for certain bench research and specialized low-flow scenarios, while hollow fiber constructs dominate clinical extracorporeal applications where surface-area-to-volume efficiency and compact form factor matter. In application contexts, the market is studied across Blood Oxygenation For Research, Cardiopulmonary Bypass, and Extracorporeal Membrane Oxygenation. Blood Oxygenation For Research is further studied across Animal Studies and In Vitro Studies, which drive material testing and preclinical performance validation; Cardiopulmonary Bypass is further studied across Coronary Artery Bypass Grafting and Valve Replacement Surgery, both of which impose distinct perfusion time profiles and anticoagulation management challenges; and Extracorporeal Membrane Oxygenation is further studied across Venoarterial ECMO and Venovenous ECMO, reflecting divergent hemodynamic and oxygenation requirements that influence membrane selection and flow architecture.

End user segmentation reveals differing procurement drivers: Ambulatory Surgical Centers, Hospitals, and Research Institutes each evaluate oxygenators through lenses of cost efficiency, clinical robustness, and experimental flexibility, respectively. Based on Material, the market is studied across Polymethylpentene, Polypropylene, and Polysulfone, with polymethylpentene increasingly preferred for long-duration extracorporeal support due to its favorable gas permeability and thermal stability, while polypropylene offers cost advantages in some disposable formats and polysulfone provides broad thermal and chemical resilience. Flow configuration analysis, based on Flow Configuration, examines Closed and Open systems, where closed-loop designs prioritize infection control and precise gas exchange control and open configurations favor simplicity and accessibility for certain surgical workflows. Temperature-driven segmentation, based on Temperature, studies Hypothermic and Normothermic use cases, recognizing that membrane performance and hemocompatibility profiles can differ under altered thermal states and that device validation must address biophysical variability across these clinical protocols. Collectively, these segmentation lenses inform design trade-offs, regulatory strategies, and targeted commercialization approaches.

Regional clinical adoption, regulatory diversity, and manufacturing capacity shape differentiated strategies across the Americas, EMEA, and Asia-Pacific markets for membrane oxygenator businesses

Regional variation influences clinical practices, regulatory pathways, and procurement frameworks in ways that matter for manufacturers and health systems alike. In the Americas, clinical adoption is shaped by concentrated centers of excellence for extracorporeal therapy, a regulatory environment that emphasizes post-market surveillance and device traceability, and supply chains that favor both domestic manufacturing and strategic imports. These dynamics create opportunities for companies that can demonstrate robust clinical data, scalable manufacturing, and responsive service models.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific procurement norms; reimbursement variability and divergent hospital tender processes require flexible commercialization models and strong clinical affairs engagement. Local manufacturing partnerships and distributor relationships frequently determine market entry speed. Asia-Pacific continues to exhibit rapid clinical adoption in selected urban centers, coupled with an expanding base of local manufacturers and contract producers capable of competing on lead time and cost. Strategic partnerships, technology transfer agreements, and region-specific regulatory strategies are essential to navigate this diverse territory and to align product portfolios with regional clinical and economic priorities.

Competitive and partnership dynamics that highlight material innovation, IP positioning, manufacturing scaling, and service-enabled differentiation among membrane oxygenator providers

Competitive dynamics in the membrane oxygenator landscape are defined by a blend of specialized manufacturers, large medical device OEMs, and nimble contract producers. Market leaders and innovative newcomers alike are investing in coating chemistries that reduce thrombogenic response, in membrane materials that extend functional duration, and in manufacturing processes that improve lot-to-lot consistency. Strategic partnerships between device designers and clinical research centers are accelerating evidence generation, while alliances with contract manufacturers and packaging specialists are enabling faster scale-up and broader geographic reach.

Intellectual property portfolios around hollow fiber geometry, surface treatment processes, and integrated sensor technologies remain strategic assets, and companies that combine strong IP protection with a clear clinical value proposition tend to secure favorable procurement outcomes. Distribution strategies vary, with some firms emphasizing direct hospital relationships and clinical training programs, while others leverage distributor networks to broaden penetration. For many players, the next wave of differentiation will come from demonstrating superior real-world performance, offering integrated clinical support services, and presenting clear pathways for regulatory compliance in key jurisdictions.

Practical and prioritized actions for executives to fortify supply chains, accelerate material innovation, modularize platforms, and deepen clinical partnerships to drive sustainable adoption

Industry leaders must adopt a multi-pronged set of actions to capture clinical trust, protect margins, and ensure supply continuity. First, prioritize supplier diversification and nearshoring where feasible to reduce exposure to import duties and logistics volatility; dual-sourcing critical inputs and qualifying alternate polymer suppliers will materially improve resilience. Second, accelerate investment in polymethylpentene processing capabilities and in validated surface treatments that demonstrably reduce hemocompatibility risks, since these attributes increasingly inform purchasing decisions among perfusionists and critical care teams. Third, design product portfolios with modularity in mind, enabling the same core oxygenator platform to address distinct use cases-such as coronary artery bypass grafting, valve replacement surgery, venoarterial ECMO, and venovenous ECMO-through targeted configurators and accessory kits.

Additionally, expand clinical engagement through structured training programs and outcome-oriented support services that reduce adoption friction in ambulatory surgical centers and community hospitals. Engage proactively with regulatory bodies to align clinical evidence generation with approval pathways and to anticipate changes in sterility and labeling requirements. Finally, adopt transparent total-cost-of-use communication with purchasers, emphasizing device reliability, lifecycle logistics, and post-market support to build durable procurement relationships in an environment of evolving trade policy and reimbursement expectations.

A rigorous multimodal research methodology combining expert interviews, clinical literature review, regulatory analysis, and supplier mapping to validate technical and commercial insights

This research draws on a layered methodology designed to ensure reproducibility, clinical relevance, and commercial applicability. Primary inputs include structured interviews with clinicians, perfusionists, procurement professionals, and manufacturing leaders to capture real-world performance expectations, procurement constraints, and operational considerations. Secondary research synthesizes peer-reviewed clinical literature, regulatory filings, device labeling, patent families, and standards guidance to validate technological claims and to establish baseline performance criteria. Supplier mapping and manufacturing capability assessments combine public filings, industry directories, and site-level intelligence to identify capacity constraints and regional production footprints.

Analytical methods emphasize triangulation: clinical insights inform interpretation of technical specifications, which are then cross-checked against manufacturing feasibility and regulatory precedent. Segmentation analysis uses validated clinical workflows and procurement behaviors to allocate qualitative demand drivers across device types, applications, end users, materials, flow configurations, and temperature protocols. Limitations include variability in country-level procurement practices and the evolving nature of trade policy, which the methodology addresses through scenario-based sensitivity checks and expert validation rounds. Ethical review procedures and confidentiality safeguards were applied during interviews to protect proprietary clinical data and to ensure compliance with research governance norms.

Strategic conclusions synthesizing clinical, technical, regulatory, and supply chain priorities to guide resilient and clinically focused decision-making in membrane oxygenation

In closing, membrane oxygenators occupy a critical nexus of clinical performance, materials engineering, and supply chain strategy. Design choices-particularly around membrane architecture, polymer selection, and surface chemistry-directly influence clinical outcomes across cardiopulmonary bypass, extracorporeal membrane oxygenation, and research applications. The interplay between regulatory expectations, decentralizing clinical settings, and emergent trade policies requires stakeholders to pursue resilient sourcing strategies, targeted clinical evidence generation, and product modularity to remain competitive.

Decision-makers should prioritize investments that align material innovation with manufacturability, while maintaining a sharp focus on clinician usability and post-market surveillance. Regional strategies must be tailored to prevailing regulatory and procurement landscapes, and companies that combine technical excellence with service-enabled offerings will be better positioned to capture long-term clinical trust. By integrating the strategic, clinical, and operational insights outlined here, industry participants can navigate near-term disruptions while advancing safer, more effective oxygenation solutions for patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Membrane Oxygenators Market, by Product Type

  • 8.1. Cardiopulmonary Bypass Oxygenators
    • 8.1.1. Adult Cardiopulmonary Oxygenators
    • 8.1.2. Pediatric Cardiopulmonary Oxygenators
    • 8.1.3. Neonatal Cardiopulmonary Oxygenators
  • 8.2. Extracorporeal Life Support Oxygenators
    • 8.2.1. Veno-Arterial ECMO Oxygenators
    • 8.2.2. Veno-Venous ECMO Oxygenators
    • 8.2.3. Hybrid / Configurable ECMO Oxygenators
  • 8.3. Integrated Oxygenator-Heat Exchangers
  • 8.4. Standalone Oxygenators (Without Heat Exchanger)

9. Membrane Oxygenators Market, by Material

  • 9.1. Polymethylpentene
  • 9.2. Polypropylene
  • 9.3. Polysulfone

10. Membrane Oxygenators Market, by Flow Configuration

  • 10.1. Closed
  • 10.2. Open

11. Membrane Oxygenators Market, by Temperature

  • 11.1. Hypothermic
  • 11.2. Normothermic

12. Membrane Oxygenators Market, by Application

  • 12.1. Blood Oxygenation For Research
    • 12.1.1. Animal Studies
    • 12.1.2. In Vitro Studies
  • 12.2. Cardiopulmonary Bypass
    • 12.2.1. Coronary Artery Bypass Grafting
    • 12.2.2. Valve Replacement Surgery
  • 12.3. Extracorporeal Membrane Oxygenation
    • 12.3.1. Venoarterial ECMO
    • 12.3.2. Venovenous ECMO

13. Membrane Oxygenators Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals & Research Institutes

14. Membrane Oxygenators Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Membrane Oxygenators Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Membrane Oxygenators Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Membrane Oxygenators Market

18. China Membrane Oxygenators Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Asahi Kasei Medical Co., Ltd.
  • 19.7. BRAILE BIOMEDICA INDUSTRIA COMERCIO E REPRESENTACOES LTDA
  • 19.8. Chalice Medical Ltd
  • 19.9. CytoSorbents Corporation
  • 19.10. Dongguan Kewei Medical Instrument Co., Ltd.
  • 19.11. EUROSETS S.r.l.
  • 19.12. Fresenius Medical Care AG & Co. KGaA
  • 19.13. Getinge AB
  • 19.14. LivaNova PLC
  • 19.15. Medtronic PLC
  • 19.16. Merck KGaA
  • 19.17. MicroPort Scientific Corporation
  • 19.18. Nikkiso Co., Ltd.
  • 19.19. Nipro Corporation
  • 19.20. Senko Medical Instrument Mfg. Co., Ltd.
  • 19.21. Shandong Weigao Group Medical Polymer Company Limited
  • 19.22. Terumo Corporation
  • 19.23. Xenios AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEMBRANE OXYGENATORS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEMBRANE OXYGENATORS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ADULT CARDIOPULMONARY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ADULT CARDIOPULMONARY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ADULT CARDIOPULMONARY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PEDIATRIC CARDIOPULMONARY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PEDIATRIC CARDIOPULMONARY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PEDIATRIC CARDIOPULMONARY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NEONATAL CARDIOPULMONARY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NEONATAL CARDIOPULMONARY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NEONATAL CARDIOPULMONARY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-ARTERIAL ECMO OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-ARTERIAL ECMO OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-ARTERIAL ECMO OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-VENOUS ECMO OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-VENOUS ECMO OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-VENOUS ECMO OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYBRID / CONFIGURABLE ECMO OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYBRID / CONFIGURABLE ECMO OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYBRID / CONFIGURABLE ECMO OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY INTEGRATED OXYGENATOR-HEAT EXCHANGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY INTEGRATED OXYGENATOR-HEAT EXCHANGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY INTEGRATED OXYGENATOR-HEAT EXCHANGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY STANDALONE OXYGENATORS (WITHOUT HEAT EXCHANGER), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY STANDALONE OXYGENATORS (WITHOUT HEAT EXCHANGER), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY STANDALONE OXYGENATORS (WITHOUT HEAT EXCHANGER), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 216. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 218. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 248. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 249. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 252. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 254. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 260. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 261. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 264. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 265. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 266. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)